Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria-Grazia Lazzaroni

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Autoimmunity Reviews|December 16, 2019
Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR databaseCamelia Frantz, Dorte Huscher, Jérôme Avouac, et al.
Autoimmunity Reviews|January 25, 2015
The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective studyArsène Mekinian, Maria Grazia Lazzaroni, Anna Kuzenko, et al.
Frontiers in Pharmacology|August 22, 2022
Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritisMaria Chiara Gerardi, Francesca Crisafulli, Antía García-Fernandez, et al.
The Journal of Rheumatology|January 17, 2017
Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for ScreeningMaria-Grazia Lazzaroni, Ilaria Cavazzana, Enrico Colombo, et al.
The Journal of Rheumatology|February 1, 2026
Prognostic and Functional Trajectories in Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Rheumatic Disease-Associated Interstitial Lung Disease: Insights From an Italian Multicenter CohortMarco Fornaro, Donato Lacedonia, Lorenzo Cavagna, et al.
Autoimmunity Reviews|April 11, 2015
Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnanciesMicaela Fredi, Maria Grazia Lazzaroni, Chiara Tani, et al.
Journal of Autoimmunity|February 19, 2018
Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndromeCecilia Beatrice Chighizola, Francesca Pregnolato, Laura Andreoli, et al.
RMD Open|February 22, 2023
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre studyCorrado Campochiaro, Giacomo De Luca, Maria-Grazia Lazzaroni, et al.
Rheumatology (Oxford, England)|May 15, 2024
Rituximab retention rate in systemic sclerosis: a long term real-life multicentre studyGiacomo De Luca, Enrico De Lorenzis, Corrado Campochiaro, et al.
Frontiers in Immunology|November 12, 2020
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid SyndromeMaria Orietta Borghi, Asmaa Beltagy, Emirena Garrafa, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Autoimmunity Reviews|December 16, 2019
Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR databaseCamelia Frantz, Dorte Huscher, Jérôme Avouac, et al.
Autoimmunity Reviews|January 25, 2015
The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective studyArsène Mekinian, Maria Grazia Lazzaroni, Anna Kuzenko, et al.
Frontiers in Pharmacology|August 22, 2022
Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritisMaria Chiara Gerardi, Francesca Crisafulli, Antía García-Fernandez, et al.
The Journal of Rheumatology|January 17, 2017
Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for ScreeningMaria-Grazia Lazzaroni, Ilaria Cavazzana, Enrico Colombo, et al.
The Journal of Rheumatology|February 1, 2026
Prognostic and Functional Trajectories in Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Rheumatic Disease-Associated Interstitial Lung Disease: Insights From an Italian Multicenter CohortMarco Fornaro, Donato Lacedonia, Lorenzo Cavagna, et al.
Autoimmunity Reviews|April 11, 2015
Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnanciesMicaela Fredi, Maria Grazia Lazzaroni, Chiara Tani, et al.
Journal of Autoimmunity|February 19, 2018
Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndromeCecilia Beatrice Chighizola, Francesca Pregnolato, Laura Andreoli, et al.
RMD Open|February 22, 2023
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre studyCorrado Campochiaro, Giacomo De Luca, Maria-Grazia Lazzaroni, et al.
Rheumatology (Oxford, England)|May 15, 2024
Rituximab retention rate in systemic sclerosis: a long term real-life multicentre studyGiacomo De Luca, Enrico De Lorenzis, Corrado Campochiaro, et al.
Frontiers in Immunology|November 12, 2020
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid SyndromeMaria Orietta Borghi, Asmaa Beltagy, Emirena Garrafa, et al.
Pageof 7